Stibenyl

Stibenyl may be available in the countries listed below.

Ingredient matches for Stibenyl

Ramipril

Ramipril is reported as an ingredient of Stibenyl in the following countries:

• Greece

International Drug Name Search

Botulinum Toxin Type A

Pronunciation: OH-na-BOT-ue-li-num-TOX-in-A
Generic Name: OnabotulinumtoxinA
Brand Name: Botox Cosmetic

Botulinum Toxin Type A may spread from the injection site to other areas of the body, causing symptoms of a serious condition called botulism. These symptoms may occur hours to weeks after you receive Botulinum Toxin Type A. Symptoms may include loss of strength; muscle weakness; double or blurred vision; drooping eyelids; hoarseness; change or loss of voice; loss of bladder control; or trouble speaking, breathing, or swallowing. The risk may be greater in children being treated for spasticity (muscle spasms), but these symptoms may also occur in adults. Botulinum Toxin Type A is not approved for use in children. Contact your doctor immediately if these symptoms occur.

Severe and sometimes fatal breathing or swallowing problems have been reported. The risk may be greater in patients who already have breathing or swallowing problems. Tell your doctor if you have or are at risk of developing breathing or swallowing problems.

Botulinum Toxin Type A is used for:

Temporarily improving the appearance of moderate to severe lines between the eyebrows in patients 65 years old or younger. It may also be used for other conditions as determined by your doctor.

Botulinum Toxin Type A is a neurotoxin. It works by blocking nerve impulses to the muscles or sweat glands, temporarily paralyzing the muscle or gland.

Do NOT use Botulinum Toxin Type A if:

• you are allergic to any ingredient in Botulinum Toxin Type A or another botulinum product


• you have an infection at the injection site


• you are pregnant

Contact your doctor or health care provider right away if any of these apply to you.

Before using Botulinum Toxin Type A:

Some medical conditions may interact with Botulinum Toxin Type A. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:

• if you are pregnant, planning to become pregnant, or are breast-feeding


• if you are taking any prescription or nonprescription medicine, herbal preparation, or dietary supplement


• if you have allergies to medicines, foods, or other substances


• if you have nerve problems or disease (eg, amyotrophic lateral sclerosis, motor neuropathy), muscle problems or disease (eg, Lambert-Eaton syndrome, myasthenia gravis), bleeding disorders, seizures, or severe weakness or wasting of the muscles at the injection site (eg, trouble raising your eyebrows, drooping eyelids)


• if you have a history of heart problems (eg, irregular heartbeat, a recent heart attack), swallowing or breathing problems (eg, asthma), or eye problems (eg, glaucoma, drooping eyelid)


• if you have a skin infection; or inflammation, scarring, or other skin disorders at the injection site


• if you plan to have surgery, especially surgery on your face, or if you have received Botulinum Toxin Type A or any other botulinum toxin within the past 4 months


• if you have weakness in your forehead muscles, have had any change in the way your face normally looks, or you have had surgery on your face


• if you are taking an allergy or cold medicine

Some MEDICINES MAY INTERACT with Botulinum Toxin Type A. Tell your health care provider if you are taking any other medicines, especially any of the following:

• Aminoglycoside antibiotics (eg, gentamicin), anticholinesterase medicines (eg, neostigmine), lincosamides (eg, clindamycin), magnesium, muscle relaxants (eg, cyclobenzaprine), neuromuscular blockers (eg, atracurium), polymyxin, quinidine, or sleep medicines (eg, zolpidem) because they may increase the risk of Botulinum Toxin Type A's side effects


• Anticoagulants (eg, warfarin) because the risk of bleeding at the injection site may be increased

This may not be a complete list of all interactions that may occur. Ask your health care provider if Botulinum Toxin Type A may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.

How to use Botulinum Toxin Type A:

Use Botulinum Toxin Type A as directed by your doctor. Check the label on the medicine for exact dosing instructions.

• Botulinum Toxin Type A comes with an extra patient information sheet called a Medication Guide. Read it carefully. Read it again each time you get Botulinum Toxin Type A refilled.


• Botulinum Toxin Type A is usually given as an injection at your doctor's office, hospital, or clinic.


• If you miss a dose of Botulinum Toxin Type A, contact your doctor right away.

Ask your health care provider any questions you may have about how to use Botulinum Toxin Type A.

Important safety information:

• Botulinum Toxin Type A may cause dizziness, drowsiness, loss of strength, weakness, blurred vision, or drooping eyelids. These effects may be worse if you take it with alcohol or certain medicines. Use Botulinum Toxin Type A with caution. Do not drive or perform other possibly unsafe tasks until you know how you react to it.


• Do NOT use more than the recommended dose or use Botulinum Toxin Type A more often than every 3 months without checking with your doctor.


• Tell your doctor or dentist that you take Botulinum Toxin Type A before you receive any medical or dental care, emergency care, or surgery.


• Do not switch brands of Botulinum Toxin Type A. Contact your doctor if you have any questions.


• Botulinum Toxin Type A contains albumin, which comes from human blood. There is a very rare risk of getting a viral disease or a central nervous system disease called Creutzfeldt-Jakob disease from products with albumin. No cases of these problems have been found in patients who have used Botulinum Toxin Type A.


• Botulinum Toxin Type A should not be used in CHILDREN younger than 18 years old; safety and effectiveness in these children have not been confirmed.


• PREGNANCY and BREAST-FEEDING: Do not use Botulinum Toxin Type A if you are pregnant. If you think you may be pregnant, contact your doctor. You will need to discuss the benefits and risks of using Botulinum Toxin Type A while you are pregnant. It is not known if Botulinum Toxin Type A is found in breast milk. If you are or will be breast-feeding while you use Botulinum Toxin Type A, check with your doctor. Discuss any possible risks to your baby.

Possible side effects of Botulinum Toxin Type A:

All medicines may cause side effects, but many people have no, or minor, side effects. Check with your doctor if any of these most COMMON side effects persist or become bothersome:

Anxiety; back pain; dizziness; drowsiness; dry mouth; dry or irritated eyes; facial pain; flu-like symptoms; headache; inability to focus eyes; increased cough; indigestion; nausea; neck pain; pain, redness, swelling, or tenderness at the injection site; runny nose; sensitivity to light; stiff or weak muscles at or near the injection site; sweating.

Seek medical attention right away if any of these SEVERE side effects occur:

Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue; unusual hoarseness); bleeding at the injection site; chest pain; difficulty swallowing or breathing; double or blurred vision or other vision changes; drooping of the upper eyelid; eyelid swelling; fainting; fever, chills, or persistent sore throat; irregular heartbeat; loss of bladder control; loss of strength; paralysis; seizures; severe or persistent muscle weakness or dizziness; shortness of breath; speech changes or problems.

This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.

See also: Botulinum Toxin Type A side effects (in more detail)

If OVERDOSE is suspected:

Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. Symptoms may include paralysis; severe muscle weakness; trouble swallowing; weak or shallow breathing.

Proper storage of Botulinum Toxin Type A:

Botulinum Toxin Type A is usually handled and stored by a health care provider. If you are using Botulinum Toxin Type A at home, store Botulinum Toxin Type A as directed by your pharmacist or health care provider. Keep Botulinum Toxin Type A out of the reach of children and away from pets.

General information:

• If you have any questions about Botulinum Toxin Type A, please talk with your doctor, pharmacist, or other health care provider.


• Botulinum Toxin Type A is to be used only by the patient for whom it is prescribed. Do not share it with other people.


• If your symptoms do not improve or if they become worse, check with your doctor.


• Check with your pharmacist about how to dispose of unused medicine.

This information is a summary only. It does not contain all information about Botulinum Toxin Type A. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.

Issue Date: February 1, 2012

Database Edition 12.1.1.002

Copyright © 2012 Wolters Kluwer Health, Inc.

More Botulinum Toxin Type A resources

• Botulinum Toxin Type A Side Effects (in more detail)
• Botulinum Toxin Type A Use in Pregnancy & Breastfeeding
• Botulinum Toxin Type A Drug Interactions
• Botulinum Toxin Type A Support Group
• 18 Reviews for Botulinum Toxin Type A - Add your own review/rating

Compare Botulinum Toxin Type A with other medications

• Blepharospasm
• Cervical Dystonia
• Dystonia
• Facial Wrinkles
• Hyperhidrosis
• Migraine Prevention
• Overactive Bladder
• Spasticity
• Strabismus
• Upper Limb Spasticity
• Urinary Incontinence

Paracetamolo

Paracetamolo may be available in the countries listed below.

Ingredient matches for Paracetamolo

Paracetamol

Paracetamolo (DCIT) is also known as Paracetamol (Rec.INN)

International Drug Name Search

Glossary

DCIT	Denominazione Comune Italiana
Rec.INN	Recommended International Nonproprietary Name (World Health Organization)

Click for further information on drug naming conventions and International Nonproprietary Names.

Latanoprost Gerolymatos

Latanoprost Gerolymatos may be available in the countries listed below.

Ingredient matches for Latanoprost Gerolymatos

Latanoprost

Latanoprost is reported as an ingredient of Latanoprost Gerolymatos in the following countries:

• Greece

International Drug Name Search

Gentalol

Gentalol may be available in the countries listed below.

Ingredient matches for Gentalol

Gentamicin

Gentamicin sulfate (a derivative of Gentamicin) is reported as an ingredient of Gentalol in the following countries:

• Japan

International Drug Name Search

Zyrox

Zyrox may be available in the countries listed below.

Ingredient matches for Zyrox

Roxithromycin

Roxithromycin is reported as an ingredient of Zyrox in the following countries:

• Myanmar

International Drug Name Search

Laboxantryl

Laboxantryl may be available in the countries listed below.

Ingredient matches for Laboxantryl

Mesalazine

Mesalazine is reported as an ingredient of Laboxantryl in the following countries:

• Greece

International Drug Name Search